Study on the Long-Term Risk of Recurrence of Anoperineal Fistula After Treatment with Anti-tumor Necrosis Factor (TNF) and Seton Drainage in Crohn's Disease : LT-SAFCD
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
This research aims to evaluate the long-term recurrence risk of perianal fistulas in Crohn's disease patients who have undergone treatment with anti-TNF therapy and seton drainage.The research seeks to identify factors influencing recurrence and assess the long term effectiveness of these treatments in preventing fistula recurrence. This study will provide insights that could enhance treatment strategies and improve patient outcomes.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Confirmed diagnosis of Crohn's disease
• drainage of an anal fistula with seton combined with the initiation of anti-TNF alpha treatment
• Patient who was treated in the digestive center of the Toulouse University Hospital for drainage of an anal fistula between January 1, 2000 and December 31, 2010
Locations
Other Locations
France
CHU de Toulouse
RECRUITING
Toulouse
Contact Information
Primary
Guillaume LE COSQUER, MD
lecosquer.g@chu-toulouse.fr
05 61 32 20 45
Backup
Tevin POLYNICE
polynice.t@chu-toulouse.fr
Time Frame
Start Date: 2024-09-17
Estimated Completion Date: 2027-08-01
Participants
Target number of participants: 81
Treatments
Crohn's patients
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Toulouse